Genetic Technologies Limited (GENE)
NASDAQ: GENE · Real-Time Price · USD
0.765
0.00 (0.00%)
Nov 14, 2024, 4:00 PM EST - Market open
Genetic Technologies Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
Cash & Equivalents | 1.02 | 1.02 | 7.85 | 11.73 | 20.9 | 14.21 | Upgrade
|
Short-Term Investments | 0.02 | 0.02 | 0.02 | 0.01 | 0 | 0 | Upgrade
|
Cash & Short-Term Investments | 1.04 | 1.04 | 7.87 | 11.74 | 20.9 | 14.22 | Upgrade
|
Cash Growth | -86.79% | -86.79% | -33.00% | -43.82% | 47.04% | 550.57% | Upgrade
|
Accounts Receivable | 0.21 | 0.21 | 0.19 | 0.44 | 0.09 | 0.04 | Upgrade
|
Other Receivables | 1.92 | 1.92 | 1.73 | 1.98 | 0.98 | 0.75 | Upgrade
|
Receivables | 2.13 | 2.13 | 1.92 | 2.42 | 1.07 | 0.79 | Upgrade
|
Inventory | 0.21 | 0.21 | 0.33 | 0.4 | 0.08 | 0.09 | Upgrade
|
Prepaid Expenses | 0.32 | 0.32 | 0.38 | 0.15 | 0.18 | 0.1 | Upgrade
|
Other Current Assets | - | - | - | 0 | - | - | Upgrade
|
Total Current Assets | 3.7 | 3.7 | 10.5 | 14.72 | 22.24 | 15.19 | Upgrade
|
Property, Plant & Equipment | 0.26 | 0.26 | 0.6 | 0.95 | 0.64 | 0.44 | Upgrade
|
Goodwill | 1.78 | 1.78 | 3.12 | 4.51 | - | - | Upgrade
|
Other Intangible Assets | 0.36 | 0.36 | 0.52 | 0.62 | - | - | Upgrade
|
Long-Term Deferred Tax Assets | 0.08 | 0.08 | 0.12 | - | - | - | Upgrade
|
Other Long-Term Assets | - | - | - | - | 0.1 | - | Upgrade
|
Total Assets | 6.19 | 6.19 | 14.86 | 20.8 | 22.97 | 15.63 | Upgrade
|
Accounts Payable | 1.46 | 1.46 | 0.84 | 1.15 | 0.27 | 0.35 | Upgrade
|
Accrued Expenses | 0.86 | 0.86 | 1.07 | 1.47 | 0.86 | 0.67 | Upgrade
|
Short-Term Debt | 0.64 | 0.64 | - | - | - | - | Upgrade
|
Current Portion of Leases | 0.21 | 0.21 | 0.3 | 0.26 | 0.18 | 0.24 | Upgrade
|
Current Unearned Revenue | 0.74 | 0.74 | 0.85 | 0.81 | 0 | - | Upgrade
|
Other Current Liabilities | 0.29 | 0.29 | 0.25 | 0.11 | 0.1 | 0.13 | Upgrade
|
Total Current Liabilities | 4.2 | 4.2 | 3.31 | 3.81 | 1.41 | 1.4 | Upgrade
|
Long-Term Debt | - | - | - | - | - | 0.05 | Upgrade
|
Long-Term Leases | 0.02 | 0.02 | 0.23 | 0.39 | 0.02 | 0.19 | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.08 | 0.08 | 0.12 | 0.15 | - | - | Upgrade
|
Other Long-Term Liabilities | 0.06 | 0.06 | 0.03 | 0.02 | 0.01 | 0 | Upgrade
|
Total Liabilities | 4.36 | 4.36 | 3.69 | 4.37 | 1.44 | 1.64 | Upgrade
|
Common Stock | 163.82 | 163.82 | 161.34 | 155.14 | 153.57 | 140.11 | Upgrade
|
Retained Earnings | -166.38 | -166.38 | -156.72 | -150.21 | -143.08 | -136.05 | Upgrade
|
Comprehensive Income & Other | 4.39 | 4.39 | 6.54 | 11.5 | 11.03 | 9.93 | Upgrade
|
Shareholders' Equity | 1.83 | 1.83 | 11.16 | 16.43 | 21.53 | 13.99 | Upgrade
|
Total Liabilities & Equity | 6.19 | 6.19 | 14.86 | 20.8 | 22.97 | 15.63 | Upgrade
|
Total Debt | 0.88 | 0.88 | 0.53 | 0.65 | 0.2 | 0.48 | Upgrade
|
Net Cash (Debt) | 0.16 | 0.16 | 7.34 | 11.09 | 20.7 | 13.73 | Upgrade
|
Net Cash Growth | -97.76% | -97.76% | -33.86% | -46.42% | 50.72% | 528.52% | Upgrade
|
Net Cash Per Share | 0.00 | 0.00 | 0.07 | 0.12 | 0.24 | 0.33 | Upgrade
|
Filing Date Shares Outstanding | 145.42 | 145.42 | 115.42 | 92.34 | 92.26 | 82.62 | Upgrade
|
Total Common Shares Outstanding | 132.22 | 132.22 | 115.42 | 92.34 | 90.17 | 75.14 | Upgrade
|
Working Capital | -0.5 | -0.5 | 7.19 | 10.91 | 20.83 | 13.8 | Upgrade
|
Book Value Per Share | 0.01 | 0.01 | 0.10 | 0.18 | 0.24 | 0.19 | Upgrade
|
Tangible Book Value | -0.31 | -0.31 | 7.53 | 11.3 | 21.53 | 13.99 | Upgrade
|
Tangible Book Value Per Share | -0.00 | -0.00 | 0.07 | 0.12 | 0.24 | 0.19 | Upgrade
|
Machinery | 1.32 | 1.32 | 1.29 | 1.29 | 1.22 | 1.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.